368 related articles for article (PubMed ID: 30037010)
1. Bioengineering of
Chenal A; Ladant D
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30037010
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis.
Skopova K; Tomalova B; Kanchev I; Rossmann P; Svedova M; Adkins I; Bibova I; Tomala J; Masin J; Guiso N; Osicka R; Sedlacek R; Kovar M; Sebo P
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396322
[TBL] [Abstract][Full Text] [Related]
3. Bioengineering of
Ladant D
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33499260
[TBL] [Abstract][Full Text] [Related]
4. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells.
Karimova G; Fayolle C; Gmira S; Ullmann A; Leclerc C; Ladant D
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12532-7. PubMed ID: 9770520
[TBL] [Abstract][Full Text] [Related]
5. Almost half of the RTX domain is dispensable for complement receptor 3 binding and cell-invasive activity of the Bordetella adenylate cyclase toxin.
Espinosa-Vinals CA; Masin J; Holubova J; Stanek O; Jurnecka D; Osicka R; Sebo P; Bumba L
J Biol Chem; 2021 Jul; 297(1):100833. PubMed ID: 34051233
[TBL] [Abstract][Full Text] [Related]
6. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18).
Guermonprez P; Khelef N; Blouin E; Rieu P; Ricciardi-Castagnoli P; Guiso N; Ladant D; Leclerc C
J Exp Med; 2001 May; 193(9):1035-44. PubMed ID: 11342588
[TBL] [Abstract][Full Text] [Related]
7. Selective Enhancement of the Cell-Permeabilizing Activity of Adenylate Cyclase Toxin Does Not Increase Virulence of
Holubova J; Juhasz A; Masin J; Stanek O; Jurnecka D; Osickova A; Sebo P; Osicka R
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769101
[TBL] [Abstract][Full Text] [Related]
8. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
Simsova M; Sebo P; Leclerc C
Int J Med Microbiol; 2004 Apr; 293(7-8):571-6. PubMed ID: 15149033
[TBL] [Abstract][Full Text] [Related]
9. Translocation and calmodulin-activation of the adenylate cyclase toxin (CyaA) of Bordetella pertussis.
Voegele A; O'Brien DP; Subrini O; Sapay N; Cannella SE; Enguéné VYN; Hessel A; Karst J; Hourdel V; Perez ACS; Davi M; Veneziano R; Chopineau J; Vachette P; Durand D; Brier S; Ladant D; Chenal A
Pathog Dis; 2018 Nov; 76(8):. PubMed ID: 30452651
[TBL] [Abstract][Full Text] [Related]
10. Functional and structural consequences of epithelial cell invasion by Bordetella pertussis adenylate cyclase toxin.
Angely C; Ladant D; Planus E; Louis B; Filoche M; Chenal A; Isabey D
PLoS One; 2020; 15(5):e0228606. PubMed ID: 32392246
[TBL] [Abstract][Full Text] [Related]
11. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C
Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151
[TBL] [Abstract][Full Text] [Related]
12. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
Fayolle C; Osickova A; Osicka R; Henry T; Rojas MJ; Saron MF; Sebo P; Leclerc C
J Virol; 2001 Aug; 75(16):7330-8. PubMed ID: 11462005
[TBL] [Abstract][Full Text] [Related]
13. Identification of a region that assists membrane insertion and translocation of the catalytic domain of Bordetella pertussis CyaA toxin.
Karst JC; Barker R; Devi U; Swann MJ; Davi M; Roser SJ; Ladant D; Chenal A
J Biol Chem; 2012 Mar; 287(12):9200-12. PubMed ID: 22241477
[TBL] [Abstract][Full Text] [Related]
14. Membrane Activity and Channel Formation of the Adenylate Cyclase Toxin (CyaA) of
Knapp O; Benz R
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32164365
[TBL] [Abstract][Full Text] [Related]
15. Bordetella adenylate cyclase toxin: a unique combination of a pore-forming moiety with a cell-invading adenylate cyclase enzyme.
Masin J; Osicka R; Bumba L; Sebo P
Pathog Dis; 2015 Nov; 73(8):ftv075. PubMed ID: 26391732
[TBL] [Abstract][Full Text] [Related]
16.
Ahmad JN; Holubova J; Benada O; Kofronova O; Stehlik L; Vasakova M; Sebo P
mBio; 2019 Sep; 10(5):. PubMed ID: 31551332
[TBL] [Abstract][Full Text] [Related]
17. Exposure to Bordetella pertussis adenylate cyclase toxin affects integrin-mediated adhesion and mechanics in alveolar epithelial cells.
Angely C; Nguyen NM; Andre Dias S; Planus E; Pelle G; Louis B; Filoche M; Chenal A; Ladant D; Isabey D
Biol Cell; 2017 Aug; 109(8):293-311. PubMed ID: 28597954
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane segments of complement receptor 3 do not participate in cytotoxic activities but determine receptor structure required for action of Bordetella adenylate cyclase toxin.
Wald T; Osickova A; Masin J; Liskova PM; Petry-Podgorska I; Matousek T; Sebo P; Osicka R
Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26802078
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recombinant Bordetella pertussis adenylate cyclase toxins carrying passenger proteins.
Gmira S; Karimova G; Ladant D
Res Microbiol; 2001 Dec; 152(10):889-900. PubMed ID: 11766964
[TBL] [Abstract][Full Text] [Related]
20. Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: Role of toxin acylation and identification of the main integrin interaction domain.
El-Azami-El-Idrissi M; Bauche C; Loucka J; Osicka R; Sebo P; Ladant D; Leclerc C
J Biol Chem; 2003 Oct; 278(40):38514-21. PubMed ID: 12885782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
